On the public citation graph
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
0 signed · 894 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archinte.165.3.265openalex-snapshot
Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population
inferredcites →https://doi.org/10.1001/jama.1994.03520210045030openalex-snapshot
The Efficacy of Influenza Vaccination in Elderly Individuals
inferredcites →https://doi.org/10.1001/jama.272.21.1661openalex-snapshot
The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial
inferredcites →https://doi.org/10.1001/jama.289.2.179openalex-snapshot
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
inferredcites →https://doi.org/10.1001/jama.292.11.1333openalex-snapshot
Influenza-Associated Hospitalizations in the United States
inferredcites →https://doi.org/10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-eopenalex-snapshot
Two-sided confidence intervals for the single proportion: comparison of seven methods
inferredcites →https://doi.org/10.1002/(sici)1097-0258(19980430)17:8<873::aid-sim779>3.0.co;2-iopenalex-snapshot
Interval estimation for the difference between independent proportions: comparison of eleven methods
inferredcites →https://doi.org/10.1016/j.vaccine.2005.04.019openalex-snapshot
The unmet need in the elderly: Designing new influenza vaccines for older adults
inferredcites →https://doi.org/10.1016/j.vaccine.2009.09.092openalex-snapshot
Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older
inferredcites →https://doi.org/10.1016/j.vaccine.2011.10.030openalex-snapshot
Seasonal influenza vaccine provision in 157 countries (2004–2009) and the potential influence of national public health policies
inferredcites →https://doi.org/10.1016/j.vaccine.2012.10.084openalex-snapshot
Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: A systematic review with meta-analyses of controlled trials
inferredcites →https://doi.org/10.1016/j.vaccine.2012.12.013openalex-snapshot
High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009–2010 season
inferredcites →https://doi.org/10.1016/j.vaccine.2013.09.074openalex-snapshot
Immunogenicity and safety of Fluzone® intradermal and high-dose influenza vaccines in older adults ≥65 years of age: A randomized, controlled, phase II trial
inferredcites →https://doi.org/10.1016/s1473-3099(11)70295-xopenalex-snapshot
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/s1473-3099(13)70046-xopenalex-snapshot
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial
inferredcites →https://doi.org/10.1037/e548312006-001openalex-snapshot
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
inferredcites →https://doi.org/10.1053/jinf.1999.0602openalex-snapshot
Clinical Efficacy and Safety of the Orally Inhaled Neuraminidase Inhibitor Zanamivir in the Treatment of Influenza: a Randomized, Double-blind, Placebo-controlled European Study
inferredcites →https://doi.org/10.1053/saep.2002.28236openalex-snapshot
Hemagglutination inhibition assays
inferredcites →https://doi.org/10.1086/514173openalex-snapshot
Improvement of Inactivated Influenza Virus Vaccines
inferredcites →https://doi.org/10.1086/599790openalex-snapshot
Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and Older
inferredcites →https://doi.org/10.1086/650486openalex-snapshot
The Diagnosis of Viral Respiratory Disease in Older Adults
inferredcites →https://doi.org/10.1093/aje/kws313openalex-snapshot
Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy
inferredcites →https://doi.org/10.1093/aje/kwt021openalex-snapshot
Re: "Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy"
inferredcites →https://doi.org/10.1093/fampra/15.1.16openalex-snapshot
The predictive value of influenza symptomatology in elderly people
inferredcites →https://doi.org/10.1111/j.1750-2659.2008.00059.xopenalex-snapshot
MF59®‐adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
inferredcites →https://doi.org/10.15585/mmwr.mm6522a3openalex-snapshot
Influenza Activity — United States, 2015–16 Season and Composition of the 2016–17 Influenza Vaccine
inferredcites →https://doi.org/10.1586/erv.10.134openalex-snapshot
Intanza®: a new intradermal vaccine for seasonal influenza
inferredcites →https://doi.org/10.7326/0003-4819-123-7-199510010-00008openalex-snapshot
The Efficacy of Influenza Vaccine in Elderly Persons
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3741251openalex-extracted
Fractures and Fall Injuries after Hospitalization for Seasonal Influenza - A National Retrospective Cohort Study
inferred← citeshttps://doi.org/10.2139/ssrn.4835932openalex-extracted
Incremental Benefit of High-Dose Compared to Standard-Dose Vaccine in Reducing Influenza Hospitalizations
inferred← citeshttps://doi.org/10.1001/jama.2019.18016openalex-snapshot
Influenza Vaccine for 2019-2020
inferred← citeshttps://doi.org/10.1001/jama.2020.23649openalex-snapshot
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease
inferred← citeshttps://doi.org/10.1001/jama.2020.23948openalex-snapshot
Influenza Vaccine for Patients With High-risk Cardiovascular Disease
inferred← citeshttps://doi.org/10.1001/jamacardio.2024.0468openalex-snapshot
Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular Disease
inferred← citeshttps://doi.org/10.1001/jamacardio.2024.3463openalex-snapshot
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target—Reply
inferred← citeshttps://doi.org/10.1001/jamacardio.2025.3460openalex-snapshot
High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults
inferred← citeshttps://doi.org/10.1001/jamainternmed.2025.7286openalex-snapshot
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Diabetes
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2020.31266openalex-snapshot
Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older Adults
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2020.37640openalex-snapshot
Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2020.4079openalex-snapshot
Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.35362openalex-snapshot
Influenza Vaccine Uptake in the Year After Concurrent vs Separate Influenza and Zoster Immunization
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2022.0527openalex-snapshot
Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2025.36889openalex-snapshot
Risk of Myocarditis or Pericarditis With High-Dose vs Standard-Dose Influenza Vaccine
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2026.10120openalex-snapshot
Adjuvanted vs High-Dose Influenza Vaccines in Older US Adults
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2026.14620openalex-snapshot
High-Dose vs Standard-Dose Influenza Vaccines in Older Adults
inferred← citeshttps://doi.org/10.1001/jamaoncol.2016.2437openalex-snapshot
Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib
inferred← citeshttps://doi.org/10.1002/agm2.12102openalex-snapshot
Recommendations for influenza and Streptococcus pneumoniae vaccination in elderly people in China
inferred← citeshttps://doi.org/10.1002/ajh.26388openalex-snapshot
Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis
inferred← citeshttps://doi.org/10.1002/cphy.c210026openalex-snapshot
Aging and Susceptibility to Pulmonary Disease
inferred← citeshttps://doi.org/10.1002/cpt.2452openalex-snapshot
Roadmap to 2030 for Drug Evaluation in Older Adults
inferred← citeshttps://doi.org/10.1002/cpt.3080openalex-snapshot
High‐Dose vs. Standard‐Dose Influenza Vaccine and Cardiopulmonary Hospitalization or Mortality: Emulating the INVESTED Trial Using Insurance Claims Data
inferred← citeshttps://doi.org/10.1002/cti2.1107openalex-snapshot
Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adults
inferred← citeshttps://doi.org/10.1002/cti2.70123openalex-snapshot
Assessing CD8 + T cell cross‐reactivity to influenza A, B and C virus‐derived peptides presented by HLA‐B*18:01
inferred← citeshttps://doi.org/10.1002/ejhf.2716openalex-snapshot
Association of Post-Vaccination Adverse Reactions After Influenza Vaccine with Mortality and Cardiopulmonary Outcomes in Patients with High-Risk Cardiovascular Disease: The INVESTED Trial
inferred← citeshttps://doi.org/10.1002/j.2040-4603.2022.tb00221.xopenalex-snapshot
Aging and Susceptibility to Pulmonary Disease
inferred← citeshttps://doi.org/10.1002/jcla.23937openalex-snapshot
Analysis of COVID‐19 vaccines: Types, thoughts, and application
inferred← citeshttps://doi.org/10.1002/jmv.27485openalex-snapshot
Host factors and vaccine efficacy: Implications for COVID‐19 vaccines
inferred← citeshttps://doi.org/10.1002/pst.1649openalex-snapshot
Control of type 1 error in a hybrid complete two‐period vaccine efficacy trial
inferred← citeshttps://doi.org/10.1002/rmv.2330openalex-snapshot
Systematic review of the efficacy, effectiveness and safety of high‐dose seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age
inferred← citeshttps://doi.org/10.1002/rmv.70020openalex-snapshot
Relative Efficacy, Effectiveness and Safety of Newer and/or Enhanced Seasonal Influenza Vaccines for the Prevention of Laboratory‐Confirmed Influenza in Individuals Aged 18 years and Over: Update of a Systematic Review
inferred← citeshttps://doi.org/10.1002/sim.8435openalex-snapshot
Assessing the prior event rate ratio method via probabilistic bias analysis on a Bayesian network
inferred← citeshttps://doi.org/10.1007/978-1-4939-9034-4_40openalex-snapshot
Respiratory Viral Infections in Transplant Recipients
inferred← citeshttps://doi.org/10.1007/978-3-030-06200-2_16openalex-snapshot
Preventing Infections and Healthy Aging
inferred← citeshttps://doi.org/10.1007/978-3-030-19922-7_9openalex-snapshot
Immunopathogenesis, Immunization, and Treatment of Infectious Diseases
inferred← citeshttps://doi.org/10.1007/978-3-030-20554-6_11openalex-snapshot
Controlling Triggers for Asthma in Older Adults: Environmental Allergens, Indoor and Outdoor Air Pollutants, and Infection
inferred← citeshttps://doi.org/10.1007/978-3-030-22009-9_69openalex-snapshot
Influenza Vaccination in Older Adults
inferred← citeshttps://doi.org/10.1007/978-3-030-57317-1_5openalex-snapshot
Immune Response to Vaccines
inferred← citeshttps://doi.org/10.1007/978-3-030-78923-7_7openalex-snapshot
Immunizations in Older Adults
inferred← citeshttps://doi.org/10.1007/978-3-030-87532-9_7openalex-snapshot
Vaccines and Vaccination Strategies for Older Adults
inferred← citeshttps://doi.org/10.1007/978-3-031-57369-9_2openalex-snapshot
Influenza: Clinical Challenges in the Twenty-First Century
inferred← citeshttps://doi.org/10.1007/978-3-032-04020-6_13openalex-snapshot
Seasonal Influenza Vaccination
inferred← citeshttps://doi.org/10.1007/978-3-319-14779-6_22-1openalex-snapshot
Infection in Kidney Transplanation
inferred← citeshttps://doi.org/10.1007/978-3-319-19617-6_22openalex-snapshot
Infection in Kidney Transplantation
inferred← citeshttps://doi.org/10.1007/978-3-319-28137-7_3openalex-snapshot
Challenges to Diagnosis and Management of Infections in Older Adults
inferred← citeshttps://doi.org/10.1007/978-3-319-43365-3_5openalex-snapshot
Effects of Ageing on the Vaccination Response
inferred← citeshttps://doi.org/10.1007/978-3-319-60471-8_4openalex-snapshot
Vaccine-Preventable Diseases and the Vaccines That Prevent Them
inferred← citeshttps://doi.org/10.1007/978-3-319-64597-1_71-1openalex-snapshot
Immunosenescence Modulation by Vaccination
inferred← citeshttps://doi.org/10.1007/978-3-319-69892-2_69-1openalex-snapshot
Influenza Vaccination in Older Adults
inferred← citeshttps://doi.org/10.1007/978-3-319-77674-3_18openalex-snapshot
Vaccines in the Immunocompromised Hosts
inferred← citeshttps://doi.org/10.1007/978-3-319-99375-1_71openalex-snapshot
Immunosenescence Modulation by Vaccination
inferred← citeshttps://doi.org/10.1007/978-981-13-7252-0_7openalex-snapshot
Travellers with Special Needs
inferred← citeshttps://doi.org/10.1007/s00108-015-3734-8openalex-snapshot
Impfungen aus pneumologischer Sicht
inferred← citeshttps://doi.org/10.1007/s00108-017-0358-1openalex-snapshot
Impfungen im höheren Lebensalter
inferred← citeshttps://doi.org/10.1007/s00108-022-01324-wopenalex-snapshot
Impfungen für das Immungedächtnis – immer wieder oder einmalig?
inferred← citeshttps://doi.org/10.1007/s00198-021-06068-1openalex-snapshot
Fractures and fall injuries after hospitalization for seasonal influenza—a national retrospective cohort study
inferred← citeshttps://doi.org/10.1007/s00391-018-1418-4openalex-snapshot
Influenza: besondere Aspekte im höheren Lebensalter
inferred← citeshttps://doi.org/10.1007/s00391-025-02496-4openalex-snapshot
Veränderungen des Immunsystems im Alter: Immunseneszenz und Auswirkungen auf Impfungen
inferred← citeshttps://doi.org/10.1007/s00393-021-01030-2openalex-snapshot
Immunogenität und Sicherheit von Hochdosis vs. Standarddosis eines inaktivierten Influenzaimpfstoffes bei Patienten mit rheumatoider Arthritis
inferred← citeshttps://doi.org/10.1007/s10096-026-05408-5openalex-snapshot
Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to Charlson Comorbidity Index: A post-hoc analysis of the DANFLU-1 randomized trial
inferred← citeshttps://doi.org/10.1007/s10157-018-1641-8openalex-snapshot
Clinical epidemiology of infectious disease among patients with chronic kidney disease
inferred← citeshttps://doi.org/10.1007/s10198-026-01894-8openalex-snapshot
Cost-effectiveness analysis of influenza vaccination with high-dose vaccine versus standard-dose quadrivalent vaccine in older adults in Spain
inferred← citeshttps://doi.org/10.1007/s10405-019-0257-3openalex-snapshot
Influenza – jeder kennt die „Grippe“ und doch wird sie immer noch unterschätzt
inferred← citeshttps://doi.org/10.1007/s10741-017-9614-7openalex-snapshot
Influenza infection and heart failure—vaccination may change heart failure prognosis?
inferred← citeshttps://doi.org/10.1007/s11606-020-06397-7openalex-snapshot
Use of High-Dose Influenza and Live Attenuated Influenza Vaccines by US Primary Care Physicians
inferred← citeshttps://doi.org/10.1007/s11739-023-03456-9openalex-snapshot
Influenza vaccination for elderly, vulnerable and high-risk subjects: a narrative review and expert opinion
inferred← citeshttps://doi.org/10.1007/s11883-021-00973-wopenalex-snapshot
Moving the Needle on Atherosclerotic Cardiovascular Disease and Heart Failure with Influenza Vaccination
inferred← citeshttps://doi.org/10.1007/s11883-025-01355-2openalex-snapshot
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 European Society of Cardiology Conference
inferred← citeshttps://doi.org/10.1007/s12181-023-00650-zopenalex-snapshot
Influenzaimpfung – Mehr als nur Influenzaschutz
inferred← citeshttps://doi.org/10.1007/s12325-020-01324-yopenalex-snapshot
A Map of Racial and Ethnic Disparities in Influenza Vaccine Uptake in the Medicare Fee-for-Service Program
inferred← citeshttps://doi.org/10.1007/s13670-014-0112-7openalex-snapshot
Community-Acquired Pneumonia in Older Adults
inferred← citeshttps://doi.org/10.1007/s13670-018-0258-9openalex-snapshot
Vaccinations for Older Adults
inferred← citeshttps://doi.org/10.1007/s15006-017-9602-9openalex-snapshot
Noch ist es nicht zu spät für die Grippe-Impfung!
inferred← citeshttps://doi.org/10.1007/s15033-026-4277-5openalex-snapshot
Die passende Influenzavakzine: Schlägt die Hochdosis die Standarddosis?
inferred← citeshttps://doi.org/10.1007/s40121-015-0076-8openalex-snapshot
A Novel Dynamic Model for Health Economic Analysis of Influenza Vaccination in the Elderly
inferred← citeshttps://doi.org/10.1007/s40121-017-0165-yopenalex-snapshot
Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II
inferred← citeshttps://doi.org/10.1007/s40121-017-0166-xopenalex-snapshot
Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I
inferred← citeshttps://doi.org/10.1007/s40121-024-00939-wopenalex-snapshot
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States
inferred← citeshttps://doi.org/10.1007/s40121-024-01079-xopenalex-snapshot
The Impact of Vaccination on COVID-19, Influenza, and Respiratory Syncytial Virus-Related Outcomes: A Narrative Review
inferred← citeshttps://doi.org/10.1007/s40138-015-0077-7openalex-snapshot
Current Influenza Vaccine Options for 2014
inferred← citeshttps://doi.org/10.1007/s40258-019-00534-yopenalex-snapshot
Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project
inferred← citeshttps://doi.org/10.1007/s40265-024-02083-8openalex-snapshot
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine
inferred← citeshttps://doi.org/10.1007/s40266-018-0597-4openalex-snapshot
Influenza Vaccination in Older Adults: Recent Innovations and Practical Applications
inferred← citeshttps://doi.org/10.1007/s40266-022-00958-7openalex-snapshot
A Cohort Study on Influenza Vaccine and All-Cause Mortality in Older Adults: Methodological Concerns and Public Health Implications
inferred← citeshttps://doi.org/10.1007/s40266-026-01284-yopenalex-snapshot
Advancing Vaccination Strategies for Older Adults: Insights of the Adult Immunization Board Meeting
inferred← citeshttps://doi.org/10.1007/s40273-023-01299-yopenalex-snapshot
Vaccinating the German Population Aged 60 Years and Over with a Quadrivalent High-Dose Inactivated Influenza Vaccine Compared to Standard-Dose Vaccines: A Transmission and Budget Impact Model
inferred← citeshttps://doi.org/10.1007/s40506-024-00270-5openalex-snapshot
Influenza Vaccination in Solid Organ Transplant Recipients: Methods to Improve Immunogenicity and Future Directions
inferred← citeshttps://doi.org/10.1007/s40520-025-03086-5openalex-snapshot
Influenza vaccination in older people: a geriatrician’s perspective
inferred← citeshttps://doi.org/10.1007/s40618-025-02586-5openalex-snapshot
Vaccination of people with solid tumors and diabetes: existing evidence and recommendations. A position statement from a multidisciplinary panel of scientific societies
inferred← citeshttps://doi.org/10.1007/s42090-017-0020-zopenalex-snapshot
So schützen Sie Senioren vor Infekten
inferred← citeshttps://doi.org/10.1007/s42090-021-1300-1openalex-snapshot
Aktuelles zur Grippeimpfung und COVID-19-Auffrischimpfung
inferred← citeshttps://doi.org/10.1007/s42247-021-00171-zopenalex-snapshot
Harnessing biomaterials for therapeutic strategies against COVID-19
inferred← citeshttps://doi.org/10.1007/s44197-024-00292-8openalex-snapshot
A Call for Adopting High-Dose Influenza Vaccines for Adults Aged 65 and Above in Gulf Cooperation Council (GCC) Countries
inferred← citeshttps://doi.org/10.1016/b978-0-12-374279-7.14016-0openalex-snapshot
Vaccination against Viruses
inferred← citeshttps://doi.org/10.1016/b978-0-12-802174-3.00021-7openalex-snapshot
Influenza Vaccines and Vaccination Strategies
inferred← citeshttps://doi.org/10.1016/b978-0-12-802302-0.00007-8openalex-snapshot
Vaccine Development in Special Populations
inferred← citeshttps://doi.org/10.1016/b978-0-323-35761-6.00002-xopenalex-snapshot
Vaccine Immunology
inferred← citeshttps://doi.org/10.1016/b978-0-323-35761-6.00031-6openalex-snapshot
Inactivated Influenza Vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-323-55435-0.00003-3openalex-snapshot
Special Considerations for Vaccines and the Elderly
inferred← citeshttps://doi.org/10.1016/b978-0-323-55435-0.00006-9openalex-snapshot
Influenza Vaccines—Are They Efficacious or Not?
inferred← citeshttps://doi.org/10.1016/b978-0-323-55435-0.00009-4openalex-snapshot
Vaccine Use in Immunocompromised Adults
inferred← citeshttps://doi.org/10.1016/b978-0-323-79058-1.00002-5openalex-snapshot
Vaccine Immunology
inferred← citeshttps://doi.org/10.1016/b978-0-323-79058-1.00033-5openalex-snapshot
Inactivated and Recombinant Influenza Vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-323-98814-8.00002-0openalex-snapshot
Principles of vaccine development
inferred← citeshttps://doi.org/10.1016/b978-1-4557-0090-5.00026-4openalex-snapshot
Inactivated influenza vaccines
inferred← citeshttps://doi.org/10.1016/b978-3-437-06282-7.50018-8openalex-snapshot
INFEKTIONSKRANKHEITEN
inferred← citeshttps://doi.org/10.1016/j.actpha.2022.03.012openalex-snapshot
Enjeux de la vaccination chez les seniors
inferred← citeshttps://doi.org/10.1016/j.ahj.2017.04.003openalex-snapshot
Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial
inferred← citeshttps://doi.org/10.1016/j.ahj.2018.05.007openalex-snapshot
High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trial
inferred← citeshttps://doi.org/10.1016/j.ahj.2021.03.007openalex-snapshot
Effectiveness of the quadrivalent high-dose influenza vaccine for prevention of cardiovascular and respiratory events in people aged 65 years and above: Rationale and design of a real-world pragmatic randomized clinical trial
inferred← citeshttps://doi.org/10.1016/j.ahj.2025.07.069openalex-snapshot
A pragmatic individually randomized trial to evaluate the effectiveness of high-dose vs standard-dose influenza vaccine in older adults: Rationale and design of the DANFLU-2 trial
inferred← citeshttps://doi.org/10.1016/j.ahj.2026.107591openalex-snapshot
Comparative effectiveness of influenza vaccination dosing strategies for cardiovascular protection: A systematic review and network meta-analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1016/j.ajt.2026.07.033openalex-snapshot
Vaccination and safe living strategies for solid organ transplant candidates and recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
inferred← citeshttps://doi.org/10.1016/j.amepre.2018.11.015openalex-snapshot
Compressed Influenza Vaccination in U.S. Older Adults: A Decision Analysis
inferred← citeshttps://doi.org/10.1016/j.amepre.2020.05.009openalex-snapshot
Characteristics of Repeated Influenza Vaccination Among Older U.S. Adults
inferred← citeshttps://doi.org/10.1016/j.amjmed.2018.02.019openalex-snapshot
Effective Immunization of Older Adults Against Seasonal Influenza
inferred← citeshttps://doi.org/10.1016/j.antinf.2017.05.001openalex-snapshot
Les vaccins dans la prévention des infections associées aux soins
inferred← citeshttps://doi.org/10.1016/j.bbmt.2015.12.003openalex-snapshot
Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients
inferred← citeshttps://doi.org/10.1016/j.berh.2016.10.009openalex-snapshot
Immunization in patients with inflammatory rheumatic diseases
inferred← citeshttps://doi.org/10.1016/j.biologicals.2026.101886openalex-snapshot
Alternative approaches to phase III clinical trials for vaccine efficacy and licensure: the role of real-world evidence – a meeting report
inferred← citeshttps://doi.org/10.1016/j.bja.2020.06.060openalex-snapshot
Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review
inferred← citeshttps://doi.org/10.1016/j.blre.2022.100984openalex-snapshot
SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies
inferred← citeshttps://doi.org/10.1016/j.carage.2016.02.008openalex-snapshot
From the March Issue of JAMDA
inferred← citeshttps://doi.org/10.1016/j.ccm.2016.11.009openalex-snapshot
Vaccines in the Prevention of Viral Pneumonia
inferred← citeshttps://doi.org/10.1016/j.cct.2019.105856openalex-snapshot
Hybrid clinical trials to generate real-world evidence: design considerations from a sponsor's perspective
inferred← citeshttps://doi.org/10.1016/j.cellimm.2019.103998openalex-snapshot
Aging and influenza vaccine-induced immunity
inferred← citeshttps://doi.org/10.1016/j.celrep.2018.10.074openalex-snapshot
Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells
inferred← citeshttps://doi.org/10.1016/j.cger.2016.03.001openalex-snapshot
Vaccinations for the Older Adult
inferred← citeshttps://doi.org/10.1016/j.cger.2016.08.009openalex-snapshot
Gaps in Aging Research as it Applies to Rheumatologic Clinical Care
inferred← citeshttps://doi.org/10.1016/j.cger.2017.08.006openalex-snapshot
Vaccinations in Older Adults
inferred← citeshttps://doi.org/10.1016/j.cger.2025.09.009openalex-snapshot
Vaccine-Preventable Diseases in Older Adults
inferred← citeshttps://doi.org/10.1016/j.chom.2019.01.002openalex-snapshot
Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals
inferred← citeshttps://doi.org/10.1016/j.cmi.2016.03.021openalex-snapshot
Seasonal influenza vaccines and hurdles to mutual protection
inferred← citeshttps://doi.org/10.1016/j.cmi.2018.05.002openalex-snapshot
Immunogenicity and reactogenicity of high- vs. standard-dose trivalent inactivated influenza vaccine in healthcare workers: a pilot randomized controlled trial
inferred← citeshttps://doi.org/10.1016/j.cmi.2024.01.017openalex-snapshot
Effectiveness of high-dose versus standard-dose quadrivalent influenza vaccine against recurrent hospitalizations and mortality in relation to influenza circulation: A post-hoc analysis of the DANFLU-1 randomized clinical trial
inferred← citeshttps://doi.org/10.1016/j.cmi.2024.08.012openalex-snapshot
The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021–2022 influenza season
inferred← citeshttps://doi.org/10.1016/j.cmi.2026.06.018openalex-snapshot
Effectiveness of high-dose versus standard-dose influenza vaccines against severe respiratory and secondary cardiovascular outcomes in adults aged ≥80 years
inferred← citeshttps://doi.org/10.1016/j.coi.2016.05.014openalex-snapshot
Viral vectors as vaccine platforms: from immunogenicity to impact
inferred← citeshttps://doi.org/10.1016/j.coi.2019.03.004openalex-snapshot
High-affinity anti-glycan antibodies: challenges and strategies
inferred← citeshttps://doi.org/10.1016/j.coviro.2016.03.003openalex-snapshot
Vaccinology in the third millennium: scientific and social challenges
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2026.105253openalex-snapshot
Bispecific antibodies in solid tumors: An Italian Association of Medical Oncology (AIOM) multidisciplinary perspective on immunology and vaccination
inferred← citeshttps://doi.org/10.1016/j.ebiom.2025.105744openalex-snapshot
Leveraging pre-vaccination antibody titres across multiple influenza H3N2 variants to forecast the post-vaccination response
inferred← citeshttps://doi.org/10.1016/j.ejim.2018.04.020openalex-snapshot
Association between influenza vaccination and the reduced risk of acute kidney injury among older people: A nested case-control study
inferred← citeshttps://doi.org/10.1016/j.exger.2017.09.015openalex-snapshot
Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage
inferred← citeshttps://doi.org/10.1016/j.exger.2019.110632openalex-snapshot
Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses
inferred← citeshttps://doi.org/10.1016/j.gerinurse.2017.12.005openalex-snapshot
What is new in the world of immunizations for 2018
inferred← citeshttps://doi.org/10.1016/j.idc.2019.02.004openalex-snapshot
Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient
inferred← citeshttps://doi.org/10.1016/j.idc.2019.02.007openalex-snapshot
Vaccination of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.134012openalex-snapshot
Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing
inferred← citeshttps://doi.org/10.1016/j.ijcard.2026.134178openalex-snapshot
Cardiovascular disease related to influenza infection and the protective role of influenza vaccination
inferred← citeshttps://doi.org/10.1016/j.ijcchd.2022.100359openalex-snapshot
T Cell Response to Influenza Vaccination Remains Intact in Adults with Congenital Heart Disease Who Underwent Early Thymectomy
inferred← citeshttps://doi.org/10.1016/j.ijid.2025.107983openalex-snapshot
Comparable effectiveness of MF59®-adjuvanted and high-dose quadrivalent inactivated influenza vaccines for prevention of test-confirmed influenza during the 2022-2023 influenza season
inferred← citeshttps://doi.org/10.1016/j.ijid.2025.108100openalex-snapshot
Relative effectiveness of the high-dose versus standard-dose influenza vaccines for the prevention of laboratory-confirmed influenza among Italian older adults during three recent seasons
inferred← citeshttps://doi.org/10.1016/j.ijregi.2026.100858openalex-snapshot
Cost-effectiveness of routine influenza vaccination program for individuals aged 65 years and older in Japan: Substituting standard-dose inactivated vaccine with high-dose inactivated vaccine
inferred← citeshttps://doi.org/10.1016/j.immuni.2017.03.010openalex-snapshot
Successful and Maladaptive T Cell Aging
inferred← citeshttps://doi.org/10.1016/j.immuni.2026.02.018openalex-snapshot
Memory T cell aging and rejuvenation
inferred← citeshttps://doi.org/10.1016/j.isci.2023.106506openalex-snapshot
COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine series
inferred← citeshttps://doi.org/10.1016/j.jacadv.2024.100897openalex-snapshot
Feasibility and Findings of Including Self-Identified Adult Congenital Heart Disease Patients in the INVESTED Trial
inferred← citeshttps://doi.org/10.1016/j.jacadv.2024.100898openalex-snapshot
Influenza Vaccination in Adult Patients With Congenital Heart Disease
inferred← citeshttps://doi.org/10.1016/j.jacc.2020.08.028openalex-snapshot
Influenza Vaccination to Reduce Cardiovascular Morbidity and Mortality in Patients With COVID-19
inferred← citeshttps://doi.org/10.1016/j.jacc.2025.09.1578openalex-snapshot
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Atrial Fibrillation
inferred← citeshttps://doi.org/10.1016/j.jacc.2025.10.005openalex-snapshot
High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease
inferred← citeshttps://doi.org/10.1016/j.jamda.2018.12.003openalex-snapshot
Cost Benefit of High-Dose vs Standard-Dose Influenza Vaccine in a Long-Term Care Population During an A/H1N1-Predominant Influenza Season
inferred← citeshttps://doi.org/10.1016/j.jamda.2025.105625openalex-snapshot
Which Enhanced Influenza Vaccine Has the Greatest Immunogenicity in Long-Term Care Residents: The Adjuvanted or the High-Dose Formulation?
inferred← citeshttps://doi.org/10.1016/j.japh.2015.12.001openalex-snapshot
High-dose influenza vaccine in older adults
inferred← citeshttps://doi.org/10.1016/j.japh.2017.08.002openalex-snapshot
Influenza vaccine formulation and effectiveness
inferred← citeshttps://doi.org/10.1016/j.jchf.2016.12.007openalex-snapshot
Can Vaccinations Improve Heart Failure Outcomes?
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2018.06.009openalex-snapshot
Patients and investigators prefer measures of absolute risk in subgroups for pragmatic randomized trials
inferred← citeshttps://doi.org/10.1016/j.jconrel.2026.115262openalex-snapshot
Nanovaccines co-delivering antigen and dual TLR agonists potentiate aged immunity by orchestrating TCR repertoire
inferred← citeshttps://doi.org/10.1016/j.jebo.2024.06.015openalex-snapshot
Vaccination as personal public-good provision
inferred← citeshttps://doi.org/10.1016/j.jinf.2021.08.028openalex-snapshot
Clinical efficacy and safety of high dose trivalent influenza vaccine in adults and immunosuppressed populations – A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.jinf.2024.106187openalex-snapshot
The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of evidence from randomized trials
inferred← citeshttps://doi.org/10.1016/j.jinf.2024.106276openalex-snapshot
Time of day for vaccination, outcomes, and relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine: A post hoc analysis of the DANFLU-1 randomized clinical trial
inferred← citeshttps://doi.org/10.1016/j.jinf.2025.106538openalex-snapshot
High-dose versus standard-dose influenza vaccine for immunocompromised patients: A systematic review and meta-analysis of randomised clinical trials
inferred← citeshttps://doi.org/10.1016/j.jiph.2025.102934openalex-snapshot
Influenza vaccine effectiveness over 17 seasons in a large Japanese cohort: Analyses by age, virus type, underlying diseases and seasons before the COVID-19 pandemic
inferred← citeshttps://doi.org/10.1016/j.jtbi.2019.05.013openalex-snapshot
Mathematical models of transmission dynamics and vaccine strategies in Hong Kong during the 2017–2018 winter influenza season
inferred← citeshttps://doi.org/10.1016/j.jvacx.2023.100327openalex-snapshot
High-dose influenza vaccine in older adults by age and seasonal characteristics: Systematic review and meta-analysis update
inferred← citeshttps://doi.org/10.1016/j.jvacx.2023.100365openalex-snapshot
Estimated health and economic impact of using high-dose influenza vaccine on respiratory and circulatory plus respiratory hospitalizations of older adults in Australia
inferred← citeshttps://doi.org/10.1016/j.jvacx.2024.100587openalex-snapshot
The clinical and economic value of enhanced influenza vaccines for the elderly in Argentina
inferred← citeshttps://doi.org/10.1016/j.jvacx.2025.100662openalex-snapshot
Seasonal influenza vaccination: Overcoming immunosenescence with enhanced vaccines
inferred← citeshttps://doi.org/10.1016/j.jval.2019.09.2747openalex-snapshot
Evaluation of Efficacy Endpoints for a Phase IIb Study of a Respiratory Syncytial Virus Vaccine in Older Adults Using Patient-Reported Outcomes With Laboratory Confirmation
inferred← citeshttps://doi.org/10.1016/j.jval.2022.03.011openalex-snapshot
Systematic Review on the Cost-Effectiveness of Seasonal Influenza Vaccines in Older Adults
inferred← citeshttps://doi.org/10.1016/j.jval.2022.11.020openalex-snapshot
Reducing Hospital Capacity Needs for Seasonal Respiratory Infections: The Case of Switching to High-Dose Influenza Vaccine for Dutch Older Adults
inferred← citeshttps://doi.org/10.1016/j.lanhl.2026.100870openalex-snapshot
Effect of high-dose versus standard-dose influenza vaccines on hospitalisation outcomes and mortality in older adults: a systematic review and meta-analysis
showing the first 200 of 866 · page through all 866
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.